Self antigen prognostic for human immunodeficiency virus disease progression

Clinical and Diagnostic Laboratory Immunology

Volumn 8, Issue 5, 2001, Pages 937-942

  Bristow, C L ^a   Patel, H ^a   Arnold, R R ^a  

^a ROCKEFELLER UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 1 ANTITRYPSIN; IMMUNOGLOBULIN G;

ARTICLE; CONTROLLED STUDY; DEGENERATIVE DISEASE; DISEASE COURSE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LUNG DISEASE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROGNOSIS; VIRUS INFECTIVITY; VIRUS LOAD;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ALPHA 1-ANTITRYPSIN; ALPHA 1-ANTITRYPSIN DEFICIENCY; AMINO ACID SEQUENCE; AUTOANTIBODIES; AUTOANTIGENS; DISEASE PROGRESSION; HIV ANTIBODIES; HIV-1; HUMANS; MOLECULAR SEQUENCE DATA; PROGNOSIS;

EID: 0034820529     PISSN: 1071412X     EISSN: None     Source Type: Journal    
DOI: 10.1128/CDLI.8.5.937-942.2001     Document Type: Article

References (30)

1. Identification of the U-937 membrane-associated proteinase interacting with the V3 loop of HIV-1 gpl20 as cathepsin G
2. Comparison of properties of membrane bound versus soluble forms of human leukocytic elastase and cathepsin G
3. Alpha 1-antitrypsin
4. Inter-alpha-trypsin inhibitor proteoglycan family - A group of proteins binding and stabilizing the extracellular matrix
5. Use of a highly purified alpha 1-antitrypsin standard to establish ranges for the common normal and deficient alpha 1-antitrypsin phenotypes
6. 2macroglobulin in human serum: Application to insulin-dependent diabetes mellitus
7. Inhibition of HIV-1 by modification of a host membrane protease
8. T cell antigen receptor immune complexes demonstrating biologic and proteolytic activity
9. Slow human immunodeficiency virus (HIV) infectivity correlated with low HIV coreceptor levels
10. Population genetics of alpha-1-antitrypsin polymorphism in US whites, US blacks and African blacks
11. 2-macroglobulin concentration in serum during pregnancy
12. The acute-phase protein response to human immunodeficiency virus infection in human subjects
13. The reference range for complexed alpha 2-macroglobulin in human plasma: Development of a new enzyme linked immunosorbent assay (ELISA) for quantification of complexed alpha 2-macrogtobulin
14. 1-antitrypsin
15. HIV and the pathogenesis of AIDS
16. HIV-specific mucosal and cellular immunity in HIV-seronegative partners of HIV-seropositive individuals
17. Mendelian inheritance in man
18. Evidence for a second alpha 2-macroglobulin receptor
19. T-cell membrane-associated serine protease, tryptase TL2, binds human immunodeficiency virus type 1 gp120 and cleaves the third-variable-domain loop of gp120. Neutralizing antibodies of human immunodeficiency virus type 1 inhibit cleavage of gp120
20. In vivo interaction between trypsin and some plasma proteins in relation to tolerance to intravenous infusion of trypsin in dog
21. The disappearance of enzyme-inhibitor complexes from the circulation of man
22. Inhibition of neutrophil elastase by alpha-1-proteinase inhibitor oxidized by activated neutrophils
23. Distinct and additive effects of elastase and endotoxin on alpha-1-proteinase inhibitor
24. Evidence for activation of complement in patients with AIDS related complex (ARC) and/or lymphoadenopathy syndrome (LAS)
25. Urinary trypsin inhibitory activity for the diagnosis of bacterial infection: A prospective study in 690 patients
26. The role of inter-α-trypsin inhibitor and other proneinase inhibitors in the plasma clearance of neutrophil elastase and plasmin
27. Initiation of autoimmunity to self-proteins complexed with viral antigens
28. Membrane complement receptors specific for bound fragments of C3
29. Soluble immune complexes in patients with diabetes mellitus: Detection and pathological significance
30. Demonstration of an active component of inter-alpha-trypsin inhibitor in the brains of Alzheimer type dementia